pI: 9.8827 |
Length (AA): 371 |
MW (Da): 40299 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 7
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
187 | 304 | 4od4 (A) | 33 | 146 | 31.00 | 0.0054 | 0.25 | 0.308406 | 1.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127401)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G44520 | protoheme IX farnesyltransferase |
Babesia bovis | BBOV_II003260 | prenyltransferase, UbiA family protein |
Brugia malayi | Bm1_37295 | protoheme IX farnesyltransferase family protein |
Candida albicans | CaO19.10676 | putative farnesyl transferase |
Candida albicans | CaO19.3167 | putative farnesyl transferase |
Caenorhabditis elegans | CELE_Y46G5A.2 | Protein Y46G5A.2 |
Dictyostelium discoideum | DDB_G0288169 | UbiA prenyltransferase family protein |
Drosophila melanogaster | Dmel_CG5037 | CG5037 gene product from transcript CG5037-RA |
Escherichia coli | b0428 | protoheme IX farnesyltransferase |
Echinococcus granulosus | EgrG_001125950 | protoheme IX farnesyltransferase |
Echinococcus granulosus | EgrG_001125900 | protoheme IX farnesyltransferase |
Echinococcus multilocularis | EmuJ_001125900 | protoheme IX farnesyltransferase |
Echinococcus multilocularis | EmuJ_001125950 | protoheme IX farnesyltransferase |
Homo sapiens | ENSG00000006695 | COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor |
Leishmania braziliensis | LbrM.23.1760 | protoheme IX farnesyltransferase, putative |
Leishmania donovani | LdBPK_231920.1 | protoheme IX farnesyltransferase, putative |
Leishmania infantum | LinJ.23.1920 | protoheme IX farnesyltransferase, putative |
Leishmania major | LmjF.23.1520 | protoheme IX farnesyltransferase, putative |
Leishmania mexicana | LmxM.23.1520 | protoheme IX farnesyltransferase, putative |
Loa Loa (eye worm) | LOAG_07170 | hypothetical protein |
Mycobacterium leprae | ML0584 | Probable cytochrome C oxidase assembly factor CtaB |
Mus musculus | ENSMUSG00000042148 | cytochrome c oxidase assembly protein 10 |
Mycobacterium tuberculosis | Rv1451 | Probable cytochrome C oxidase assembly factor CtaB |
Mycobacterium ulcerans | MUL_1845 | protoheme IX farnesyltransferase |
Neospora caninum | NCLIV_044090 | cytochrome c oxidase assembly protein, putative |
Plasmodium berghei | PBANKA_1234100 | protoheme IX farnesyltransferase, putative |
Plasmodium falciparum | PF3D7_0519300 | protoheme IX farnesyltransferase, putative |
Plasmodium knowlesi | PKNH_1013800 | protoheme IX farnesyltransferase, putative |
Plasmodium vivax | PVX_080280 | cytochrome c oxidase assembly protein (heme A: farnesyltransferase), putative |
Plasmodium yoelii | PY06214 | protoheme IX farnesyltransferase, putative |
Saccharomyces cerevisiae | YPL172C | Cox10p |
Schistosoma japonicum | Sjp_0202080 | ko:K02257 protoheme IX farnesyltransferase, putative |
Schistosoma japonicum | Sjp_0012040 | Armadillo repeat-containing protein 7, putative |
Schistosoma mansoni | Smp_057930 | protoheme IX farnesyltransferase |
Schmidtea mediterranea | mk4.021419.02 | Protoheme IX farnesyltransferase, mitochondrial |
Schmidtea mediterranea | mk4.011530.01 | Protoheme IX farnesyltransferase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.5.1800 | protoheme IX farnesyltransferase, putative |
Trypanosoma brucei | Tb927.5.1310 | protoheme IX farnesyltransferase, putative |
Trypanosoma congolense | TcIL3000_5_1330 | protoheme IX farnesyltransferase, putative |
Trypanosoma cruzi | TcCLB.509601.59 | protoheme IX farnesyltransferase, putative |
Trypanosoma cruzi | TcCLB.509767.59 | protoheme IX farnesyltransferase, putative |
Toxoplasma gondii | TGME49_206310 | prenyltransferase, UbiA family protein |
Theileria parva | TP04_0267 | farnesyltransferase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0306 | protoheme IX farnesyltransferase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.1310 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1310 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1310 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.5.1310 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0428 | Escherichia coli | non-essential | goodall |
TGME49_206310 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
12 literature references were collected for this gene.